We are delighted to present the latest addition to our laboratory: the BD FACSLyric™ Flow Cytometry System. This cutting-edge system represents a significant enhancement to our existing flow cytometry platform, which already includes the BD FACS Aria III and the Apogee A50micro.
The key advantages of the BD FACSLyric™ system lies in its automation and standardization capabilities, ensuring consistent and reliable results across all experiments. This means that data comparability between different laboratories is greatly enhanced, which facilitates on the one hand collaboration with partners and on the other hand the integrity of our research outcomes. With this acquisition, we substantially support our services in core areas such as Immunogenicity Prediction, Cellular Immune Monitoring, and Cell-Based Assays.
The addition of the BD FACSLyric™ underscores our commitment to innovation and excellence. For inquiries or further information, please don’t hesitate to reach out to us.
